Cergentis launches TLA technology for
complete cancer gene mutation sequencing


Read press release



TLA Technology

Uniquely, TLA enables targeted, complete, cost-effective Next Generation Sequencing

Services & Kits

Cergentis provides services and kits for targeted NGS sequencing of any (trans)gene of interest

Our Mission

To improve the quality of genetic research and human healthcare by enabling cost-effective complete sequencing of relevant genes.


Learn more

© 2012-2019 Cergentis B.V. All rights reserved.
For Research Use Only.Not for use in diagnostic procedures.
We use cookies for website analysis and marketing. By visiting and using our website you accept these cookies.